Minerva Surgical to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Minerva Surgical, a company focused on women's health, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 11:15 a.m. ET. The presentation will address strategies for treating Abnormal Uterine Bleeding (AUB). A live audio webcast will be available on Minerva's website for 30 days following the event.

Minerva specializes in minimally invasive surgical solutions aimed at reducing the need for hysterectomies and addressing common causes of AUB, offering alternatives tailored to women's distinct healthcare needs.

News Market Reaction – UTRS

+2.83%

+2.83% Session move

In the trading session that priced this news, UTRS gained 2.83%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 40^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 11:15 a.m. Eastern Time.

A live audio webcast and replay of the presentation may be accessed for 30 days through the “Recent Events” section of Minerva’s website at http://ir.minervasurgical.com.

ABOUT MINERVA SURGICAL – THE UTERINE HEALTH COMPANY

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

MEDIA CONTACT

Mike Clapper
mike.clapper@minervasurgical.com
804-295-7676

INVESTOR RELATIONS CONTACT

Caroline Corner
investors@minervasurgical.com
415-202-5678

RELATED LINKS

https://www.aubandme.com

https://www.minervasurgical.com

FAQ

When is Minerva Surgical presenting at the J.P. Morgan Healthcare Conference?

Minerva Surgical will present on January 12, 2022, at 11:15 a.m. Eastern Time.

What is the focus of Minerva Surgical's presentation at the conference?

The presentation will focus on strategies for treating Abnormal Uterine Bleeding (AUB).

Where can I access the webcast of Minerva Surgical's presentation?

The live audio webcast can be accessed on Minerva's website for 30 days after the event.

What does Minerva Surgical specialize in?

Minerva Surgical specializes in minimally invasive surgical solutions for women's uterine health.

What are the alternatives Minerva offers for treating AUB?

Minerva offers minimally invasive alternatives to hysterectomies tailored to the healthcare needs of women.